Epilepsy Carbamazepine tablets are indicated for use as an anticonvulsant drug. Evidence supporting efficacy of carbamazepine as an anticonvulsant was derived from active drug-controlled studies that enrolled patients with the following seizure types: Partial seizures with complex symptomatology (psychomotor, temporal lobe).
From the U.S. FDA-approved label for Carbamazepine. Full label: DailyMed.
Epilepsy Carbamazepine tablets are indicated for use as an anticonvulsant drug. Evidence supporting efficacy of carbamazepine as an anticonvulsant was derived from active drug-controlled studies that enrolled patients with the following seizure types: Partial seizures with complex symptomatology (psychomotor, temporal lobe). Patients with these seizures appear to show greater improvement than those with other types. Generalized tonic-clonic seizures (grand mal). Mixed seizure patterns which include the above, or other partial or generalized seizures. Absence seizures (petit mal) do not appear to be controlled by carbamazepine ( see PRECAUTIONS, General ).
From the U.S. FDA-approved label for Carbamazepine. Full label: DailyMed.
(SEE TABLE BELOW) Monitoring of blood levels has increased the efficacy and safety of anticonvulsants ( see PRECAUTIONS, Laboratory Tests ). Dosage should be adjusted to the needs of the individual patient. A low initial daily dosage with a gradual increase is advised.
Directions from the U.S. FDA-approved label for Carbamazepine — your doctor or pharmacist may advise differently.
Carbamazepine should not be used in patients with a history of previous bone marrow depression, hypersensitivity to the drug, or known sensitivity to any of the tricyclic compounds, such as amitriptyline, desipramine, imipramine, protriptyline, nortriptyline, etc. Likewise, on theoretical grounds its use with monoamine oxidase (MAO) inhibitors is not recommended. Before administration of carbamazepine, MAO inhibitors should be discontinued for a minimum of 14 days, or longer if the clinical situation permits.
Excerpt from the U.S. FDA-approved label for Carbamazepine. Talk to a pharmacist or doctor before use.
Serious Dermatologic Reactions Serious and sometimes fatal dermatologic reactions, including toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS), have been reported with carbamazepine treatment. The risk of these events is estimated to be about 1 to 6 per 10,000 new users in countries with mainly Caucasian populations. However, the risk in some Asian countries is estimated to be about 10 times higher. Carbamazepine should be discontinued at the first sign of a rash, unless the rash is clearly not drug related.
Warnings and precautions excerpt from the U.S. FDA-approved label for Carbamazepine — not a complete list. Talk to a pharmacist or doctor before use.
If adverse reactions are of such severity that the drug must be discontinued, the physician must be aware that abrupt discontinuation of any anticonvulsant drug in a responsive epileptic patient may lead to seizures or even status epilepticus with its life-threatening hazards.
Excerpt from the U.S. FDA-approved label for Carbamazepine — not a complete list. Talk to a pharmacist or doctor about side effects.
51 brands · 14 makers in the NepalDoc catalog — see the full Carbamazepine guide →
Store at 20° to 25°C (68° to 77°F). Protect from light and moisture.
Storage information from the U.S. FDA-approved label for Carbamazepine.
What is Tegrital?
Tegrital 100mg Syrup is a Carbamazepine medicine made by Novartis India Ltd. It comes as 100mg Syrup.
What is Tegrital used for?
According to its FDA label, Carbamazepine is used as an anticonvulsant drug.
What is the generic name of Tegrital?
The generic name of Tegrital is Carbamazepine.
Which brands of Carbamazepine are available in Nepal?
51 brands of Carbamazepine are listed in the NepalDoc catalog, from 14 makers — including Bazetol 100mg Tablet, Bazetol 100 XR 100mg Tablet, Bazetol 200mg Tablet, Bazetol 200 XR 200mg Tablet, Bazetol 400 XR 400mg Tablet, Bezetol 100mg Tablet.
What are the side effects of Carbamazepine?
If adverse reactions are of such severity that the drug must be discontinued, the physician must be aware that abrupt discontinuation of any anticonvulsant drug in a responsive epileptic patient may lead to seizures or even status epilepticus with its life-threatening hazards.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
Every NepalDoc section, one tap away.
Find doctors by specialty across Nepal.
